Liquid biopsy allows noninvasive
and real-time analysis of tumor-derived
circulating targets in body fluids, holding great value for cancer
diagnosis, prognosis, personalized therapy, as well as the understanding
of mechanisms underlying tumorigenesis and progression. However, the
low concentration and heterogeneity of circulating targets and the
complexity of body fluids bring daunting technical challenges to liquid
biopsy. Aptamers with many unique properties are considered as promising
recognition ligands for liquid biopsy. Their facile modification and
affinity regulation afford numerous platforms for efficient isolation
and release of circulating targets. With versatile structural design
and engineering, aptamers also offer many strategies for sensitive
detection and analysis of circulating targets. In this review, recent
progress in aptamer-based liquid biopsy is summarized, with a focus
on the isolation and detection of circulating tumor cells (CTCs) and
extracellular vesicles (EVs). First, recently emerged strategies for
evolving aptamers against circulating targets are introduced, and
existing aptamers successfully applied in the liquid biopsy are comprehensively
summarized, including their targets, sequences, affinities, etc. Then,
aptamer-based approaches for CTC isolation, release, and analysis
are summarized. Additionally, aptamer-mediated signal transduction
and amplification for the detection of EVs are also reviewed. Finally,
the challenges and future perspectives in this field are discussed.